A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndromePerrine Soret, Doreen Belz, Carlos Vasconcelos et al.|Nature Communications|2021Cited by 166
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19Emiko Desvaux, Philippe Moingeon, Sandra Hubert et al.|PLoS ONE|2021Cited by 18
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjögren's diseaseCheïma Boudjeniba, Étienne Becht, Emiko Desvaux et al.|Clinical Immunology|2024Cited by 2
Consensus gene modules strategy identifies candidate blood-based biomarkers for primary Sjogren's diseaseCheïma Boudjeniba, Étienne Becht, Emiko Desvaux et al.|medRxiv|2023Cited by 0